Abstract is: Hydroxocobalamin, also known as vitamin B12a and hydroxycobalamin, is a vitamin found in food and used as a dietary supplement. As a supplement it is used to treat vitamin B12 deficiency including pernicious anemia. Other uses include treatment for cyanide poisoning, Leber's optic atrophy, and toxic amblyopia. It is given by injection into a muscle or vein. Side effects are generally few. They may include diarrhea, low blood potassium, allergic reactions, and high blood pressure. Normal doses are considered safe in pregnancy. Hydroxocobalamin is the natural form of vitamin B12 and a member of the cobalamin family of compounds. Hydroxocobalamin, or another form of vitamin B12, are required for the body to make DNA. Hydroxocobalamin was first isolated in 1949. It is on the World Health Organization's List of Essential Medicines. Hydroxocobalamin is available as a generic medication. Commercially it is made using one of a number of types of bacteria.
| P3780 | active ingredient in | Cyanokit | Q29005682 |
| P4250 | defined daily dose | 20 | |
| P527 | has part(s) | carbon | Q623 |
| cobalt | Q740 | ||
| P366 | has use | medication | Q12140 |
| P3776 | inhibitor of | non-structural protein 5 [SARS-CoV-2] | Q87917582 |
| P2067 | mass | 1345.5670657779997 | |
| 1345.567065778 | |||
| P2175 | medical condition treated | multiple sclerosis | Q8277 |
| pernicious anemia | Q1346016 | ||
| alcoholic neuropathy | Q4062508 | ||
| diabetic polyneuropathy | Q4160985 | ||
| P2868 | subject has role | essential medicine | Q35456 |
| vitamin B | Q183206 | ||
| hematinic | Q10860580 | ||
| P2275 | World Health Organisation international non-proprietary name | hydroxocobalamin |
| Q93328895 | A Randomized Controlled Trial of Mecobalamin Injection and Tablet Treatment Efficacy on Mild to Moderate Diabetic Peripheral Neuropathy |
| Q61924715 | A Study in Patients With Amyotrophic Lateral Sclerosis (ALS) |
| Q86313710 | A Study of Telaglenastat (CB-839) With Standard-of-Care Chemoimmunotherapy in 1L KEAP1/NRF2-Mutated, Nonsquamous NSCLC |
| Q63592964 | A Trial of Vitamin B12 in Septic Shock |
| Q63581424 | Administration of Methionine in Patients With Pulmonary Alveolar Proteinosis by Mutation of the MARS Gene. |
| Q63340720 | Animal Source Food Supplement and Pregnancy in Vietnam |
| Q92271913 | Assessment of Serum Levels of Vitamin D, Vitamin B12 and Folic Acid Among Patients With Lifelong Premature Ejaculation and Non-responding to Dapoxetine Treatment. |
| Q92271815 | Autologous Tansfusion REquirements in Bone MArrow Harvest: The ATREMA Study |
| Q62104864 | BVAIT: B-Vitamin Atherosclerosis Intervention Trial |
| Q63588121 | Can B12 and Folate Levels Predict HPV Penetration in Patients With ASCUS? |
| Q63337571 | China Stroke Secondary Prevention Trial |
| Q87076650 | Cobalamin Deficiency - Diagnosis and Therapy |
| Q113894439 | Do Iron And Vitamin B12 Injections Given Together, Improve Hemoglobin In Patients On Hemodialysis? |
| Q113887296 | Effect of Preoperative Intervention With Folic Acid and Vitamin B12 on Postoperative Neurobehavioral Changes in Children |
| Q90692524 | Effect of Ultra-short-term Treatment of Patients With Iron Deficiency or Anemia Undergoing Adolescent Scoliosis Correction |
| Q63401734 | Effects of Vitamin B12 Treatment in Singers |
| Q63595269 | Effects of Vitamin B12 on the Body's Internal Clock |
| Q63338939 | Efficacy and Safety Study of Oral Eligen® B12 in Subjects With Low Serum Cobalamin |
| Q63321002 | Efficacy of a Novel Multivitamin-Mineral Supplement in Preventing Vitamin Deficiency in Postoperative Bariatric Patients |
| Q63395028 | Evaluate the Neuroprotective Effect of Vitamin B6 and Vitamin B12 Against Vincristine Induced Neurotoxicity in Acute Lymphoblastic Leukaemia Patients |
| Q113939324 | Evaluation of Aminobutyric Acid, Glutamic Acid, Calcium, Thiamine, Pyridoxine and Cyanocobalamin as Therapy for Vertigo |
| Q95799537 | Evaluation of the Relationship Between Zinc Vitamin D and b12 Levels in the Covid-19 Positive Pregnant Women |
| Q113945344 | Factors Predicting Erythropoietin Responsiveness in Children on Hemodialysis at Sohag University Hospital |
| Q94361278 | GLP-1 Therapy: The Role of IL-6 Signaling and Adipose Tissue Remodeling in Metabolic Response |
| Q63401761 | Hemodynamic Effects of Methylene Blue vs Hydroxocobalamin in Patients at Risk of Vasoplegia During Cardiac Surgery |
| Q86282672 | Hydroxocobalamin Approach to Reduction of Calprotectin With Butyrate for Ulcerative Colitis Research |
| Q63320672 | Impact of Vitamin B12 Supplementation With Iron and Folic Acid on Adolescent Girls |
| Q94982302 | International ALLIANCE Study of Therapies to Prevent Progression of COVID-19 |
| Q61957673 | Intracoronary Administration of Levosimendan in Cardiac Surgery Patients |
| Q113943304 | Intrathecal Pemetrexed for Leptomeningeal Metastasis |
| Q63592958 | Maternal B12 Supplementation to Improve Infant B12 Deficiency and Neurodevelopment |
| Q61957366 | Metanx Effects on Nerve Fiber Density in Neuropathic Diabetics |
| Q63317194 | Myo-inositol Versus D-chiro-inositol in the Treatment of Polycystic Ovary Syndrome and Insulin Resistance: Evaluation of Clinical, Metabolic, Endocrine and Ultrasound Parameters |
| Q63339106 | Oral Cyanocobalamin (Eligen B12) Bioavailability Study |
| Q62105171 | Oral Vitamin B12 Supplementation and Cognitive Performance in Elderly People |
| Q63320915 | Oral/Intramuscular B12 to Treat Cobalamin Deficiency |
| Q62809601 | Preoperative Vitamin B12 and Folic Acid on POCD in Elderly Non-cardiac Surgical Patients |
| Q95718285 | Quadruple Fortified Salt Clinical Trial |
| Q61914782 | Randomized Trial of Vitamin B12 in Pregnant Indian Women |
| Q62030696 | Recombinant Bovine Basic Fibroblast Growth Factor for the Treatment of Radiation Induced Oral Mucositis |
| Q63393590 | Study of Pembrolizumab With Pemetrexed and Oxaliplatin in Chemo-Refractory Metastatic Colorectal Cancer Patients |
| Q113915916 | Study of Pemetrexed+Platinum Chemotherapy With or Without Cosibelimab (CK-301) in First Line Metastatic Non-squamous Non-Small Cell Lung Cancer |
| Q61934419 | Study of Pralatrexate With Vitamin B12 and Folic Acid in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma |
| Q63338928 | The Association Between Religious Origin and Age, and Vitamin B12 and Folic Acid Plasma Levels in Non Jewish Population in Western Galilee |
| Q61955299 | To Evaluate the Efficacy and Safety of Vitamin B12 Contains Extract of Lamb's Stomach in Treatment of Chronic Atrophic Gastritis (CAG) |
| Q105493276 | Vitamin B12 Biomarker Responses to Supplementation |
| Q63397229 | Vitamin B12 Pregnancy Supplementation |
| Q63229006 | Vitamin B12 Supplementation During Pregnancy on Cognitive Development |
| Q113913184 | Vitamin B12 Supplementation in Diabetic Neuropathy |
| Q63229188 | Vitamin B12 for Aromatase Inhibitors Musculoskeletal Symptoms |
| Q63585497 | Vitamin B12 for Carpal Tunnel Syndrome |
| Q63594987 | Vitamin B6 and B12 in the Treatment of Movement Disorders Induced by Antipsychotics |
| Q63340438 | Vitamin B6, B12, Folic Acid and Exercise in Parkinson's Disease |
| Q37652989 | A double-blind, randomized, comparative study of the use of a combination of uridine triphosphate trisodium, cytidine monophosphate disodium, and hydroxocobalamin, versus isolated treatment with hydroxocobalamin, in patients presenting with compress |
| Q48893352 | A fatal case of acute hydrogen sulfide poisoning caused by hydrogen sulfide: hydroxocobalamin therapy for acute hydrogen sulfide poisoning |
| Q74008026 | A method for the differentiation of hydroxocobalamin from cyanocobalamin employing the ascorbic acid reaction |
| Q72039526 | A method of measuring the serum bindng of hydroxocobalamin |
| Q90690205 | A prospective, randomized trial of intravenous hydroxocobalamin versus noradrenaline or saline for treatment of lipopolysaccharide-induced hypotension in a swine model |
| Q41322643 | A prospective, randomized trial of intravenous hydroxocobalamin versus whole blood transfusion compared to no treatment for Class III hemorrhagic shock resuscitation in a prehospital swine model |
| Q71797194 | Absorption of Cyanocobalamin, Coenzyme B12, Methylcobalamin, and Hydroxocobalamin at Different Dose Levels |
| Q47609698 | Acquired methemoglobinemia after hydroxocobalamin administration in a patient with burns and inhalation injury |
| Q70651687 | Action of a massive dose of hydroxocobalamin in acute cyanide poisoning. (Apropos of a case) |
| Q61836298 | Acute Cyanide Intoxication Treated with a Combination of Hydroxycobalamin, Sodium Nitrite, and Sodium Thiosulfate |
| Q42120984 | Acute Cyanide Poisoning: Hydroxocobalamin and Sodium Thiosulfate Treatments with Two Outcomes following One Exposure Event |
| Q36513393 | Acute hydrocyanic acid intoxication. Current data on the metabolism of cyanide and treatment by hydroxocobalamin |
| Q74540951 | Allergy to hydroxycobalamin, with tolerance of cyanocobalamin |
| Q50540060 | An evaluation of the interference of hydroxycobalamin with chemistry and co-oximetry tests on nine commonly used instruments. |
| Q73136603 | Anaphylactic reaction to hydroxycobalamin |
| Q83531940 | Anaphylactic reaction to hydroxycobalamin with tolerance to cyanocobalamin |
| Q66837952 | Anaphylactic shock caused by hydroxocobalamin |
| Q43228422 | Anaphylactoid reaction to hydroxycobalamin with tolerance of cyanocobalamin. |
| Q70618170 | Antibody to transcobalamin II and B12 binding capacity in patients treated with hydroxocobalamin |
| Q48612042 | Antidote treatment for cyanide poisoning with hydroxocobalamin causes bright pink discolouration and chemical-analytical interferences. |
| Q58965139 | Applicability of Hydroxocobalamin as a Long-acting Vitamin B12 |
| Q92213214 | Association between hydroxocobalamin administration and acute kidney injury after smoke inhalation: a multicenter retrospective study |
| Q85245132 | BNF recommends hydroxocobalamin rather than cyanocobalamin for vitamin B12 deficiency |
| Q34456976 | Biochemical and clinical response to hydroxocobalamin versus cyanocobalamin treatment in patients with methylmalonic acidemia and homocystinuria (cblC). |
| Q34549609 | Biosynthesis of 32P-labelled hydroxocobalamin and a study of its behaviour in rats |
| Q41884090 | Biphasic modulation of NOS expression, protein and nitrite products by hydroxocobalamin underlies its protective effect in endotoxemic shock: downstream regulation of COX-2, IL-1β, TNF-α, IL-6, and HMGB1 expression |
| Q42116939 | Blockade of nitrergic transmission by hydroquinone, hydroxocobalamin and carboxy-PTIO in bovine retractor penis: role of superoxide anion |
| Q76477755 | Blood cholesterol and the lipoprotein picture in women of climacteric age treated with hydroxocobalamin and amino acids |
| Q76479896 | Blood levels of vitamin B-12 in pregnant women at term and in fetuses after treatment with hydroxocobalamin and cyanocobalamin |
| Q71089572 | Body retention of hydroxocobalamin and cyanocobalamin. BNL 6942 |
| Q97900763 | Burn depth assessment after hydroxocobalamin administration |
| Q77091973 | CHEMICAL AND BIOCHEMICAL STUDIES OF VITAMIN B12 AND ITS RELATED COMPOUNDS. 13. COMPARISON OF AVAILABILITIES OF CYANOCOBALAMIN AND HYDROXOCOBALAMIN IN 5,6-DIMETHYLBENZIMIDAZOLYCOBAMIDE COENZYME FORMATION BY PROPIONIBACTERIUM SHERMANII |
| Q76531148 | CHEMICAL STUDIES ON VITAMIN B12 AND ITS RELATED COMPOUNDS. III. ON THE BIOLOGICAL ACTIVITY OF HYDROXOCOBALAMIN FOR OCHROMONAS MALHAMENSIS |
| Q76857068 | CHEMICAL STUDIES ON VITAMIN B12 AND ITS RELATED COMPOUNDS. VII. PAPER-ELECTROPHORETIC EXAMINATION ON COBAMIDES IN PROPIONIBACTERIUM SHERMANII CELLS CULTIVATED IN THE PRESENCE OF HYDROXOCOBALAMIN OR CYANOCOBALAMIN |
| Q67260356 | Carbon monoxide production from hydroxocobalamin by bacteria |
| Q91689660 | Cardiopulmonary Bypass Ultrafiltrate Discoloration After Hydroxocobalamin Administration |
| Q51735573 | Case report of high-dose hydroxocobalamin in the treatment of vasoplegic syndrome during liver transplantation. |
| Q71168753 | Cerebrospinal fluid binding capacity for cyano- and hydroxocobalamin |
| Q81536496 | Changes in blood pressure after administration of hydroxocobalamin: relationship to changes in plasma cobalamins-(III) concentrations in healthy volunteers |
| Q81506708 | Clarifications regarding interference of hydroxocobalamin with carboxyhemoglobin measurements in victims of smoke inhalation |
| Q50927442 | Clinical and biochemical outcome after hydroxocobalamin dose escalation in a series of patients with cobalamin C deficiency. |
| Q90181456 | Cobalt Blues: A New Complication of Hydroxocobalamin Therapy for Vasopressor-Resistant Vasoplegia in Patients Treated With Chronic Renal Replacement Therapy? |
| Q46388407 | Combined administration of hyperbaric oxygen and hydroxocobalamin improves cerebral metabolism after acute cyanide poisoning in rats |
| Q73308641 | Common vitamin B complex agents and folic acid: Part II. Hydroxocobalamin (vitamin B12a [AlphaRedisor; Codroxomin; Droxomin] and folic acid (vitamin B complex [Folvite]) |
| Q46696266 | Comparative effects of hydroxocobalamin and cyanocobalamin on plasma homocysteine concentrations in end-stage renal disease |
| Q72326819 | Comparative study of the Schilling test using cyanocobalamin, hydroxocobalamin and coenzyme B12 |
| Q88289855 | Comparative study of the tissue distribution of equimolar repeated doses of hydroxocobalamin and cobalt chloride in the rats |
| Q82996552 | Comparison of Reductive Dechlorination of Hexachloro-1,3-butadiene in Rhine Sediment and Model Systems with Hydroxocobalamin |
| Q33538242 | Comparison of cobinamide to hydroxocobalamin in reversing cyanide physiologic effects in rabbits using diffuse optical spectroscopy monitoring |
| Q70073306 | Comparison of hydroxocobalamin and cyanocobalamin in the treatment of pernicious anaemia |
| Q35873394 | Comparison of the effects of hydroxocobalamin and oxyhaemoglobin on responses to NO, EDRF and the nitrergic transmitter |
| Q42289379 | Comparison of the hemodynamic effects of hydroxocobalamin and cobalt edetate at equipotent cyanide antidotal doses in conscious dogs |
| Q41247749 | Complexation of intracellular cyanide by hydroxocobalamin using a human cellular model |
| Q34718072 | Congenital methylmalonic aciduria--homocystinuria with megaloblastic anemia: observations on response to hydroxocobalamin and on the effect of homocysteine and methionine on the deoxyuridine suppression test |
| Q37071694 | Controlled trial of hydroxocobalamin and riboflavine in Nigerian ataxic neuropathy |
| Q37849352 | Cyanide intoxication as part of smoke inhalation--a review on diagnosis and treatment from the emergency perspective. |
| Q73299171 | Cyanocobalamin and hydroxocobalamin in vitamin B12 injections |
| Q69581830 | Dependence of 5-methyltetrahydrofolate utilization by L5178Y murine leukemia cells in vitro on the presence of hydroxycobalamin and transcobalamin II |
| Q49277877 | Depletion of extracellular cysteine with hydroxocobalamin and ascorbate in experimental murine cancer chemotherapy |
| Q42283961 | Determination of hydroxocobalamin and cyanocobalamin by derivative spectrophotometry in cyanide poisoning |
| Q99240765 | Development of infantile tremor syndrome after initiation of hydroxycobalamin treatment in an infant with a late diagnosis of cobalamin C disorder |
| Q35870934 | Differential effects of hydroxocobalamin on NO-mediated relaxations in rat aorta and anococcygeus muscle |
| Q72615578 | Differential effects of hydroxocobalamin on relaxations induced by nitrosothiols in rat aorta and anococcygeus muscle |
| Q70628838 | Direct spectrophotometric determination of methylcobalamin and hydroxocobalamin in binary mixture. Evaluation of the stability of methylcobalamin in aqueous solutions |
| Q37052549 | Discoloration of skin and urine after treatment with hydroxocobalamin for cyanide poisoning |
| Q68082218 | Do antidotes have a future? The example of 4-methylpyrazole and hydroxocobalamin |
| Q71510767 | Dosage of hydroxocobalamin (Vibeden) |
| Q44230001 | Dosage of hydroxocobalamin for vitamin B12 deficiency |
| Q48709417 | EEG in assessing hydroxycobalamin therapy in neonatal methylmalonic aciduria with homocystinuria |
| Q78347706 | EXPERIENCES WITH A HYDROXOCOBALAMIN PREPARATION (NEUROGRISEVIT) IN NEUROLOGY |
| Q42921302 | Effect of ascorbic acid on the degradation of cyanocobalamin and hydroxocobalamin in aqueous solution: a kinetic study |
| Q73253964 | Effect of hydroquinone, hydroxocobalamin and carboxy-PTIO on non-adrenergic non-cholinergic nerve mediated relaxations of the rat duodenum |
| Q41969784 | Effect of hydroxocobalamin on surface oximetry in nonexposed humans |
| Q74429426 | Effect of hydroxocobalamin on vasodilatations to nitrergic transmitter, nitric oxide and endothelium-derived relaxing factor in guinea-pig basilar artery |
| Q39965207 | Effect of hydroxycobalamin on the inhibition of cytochrome c oxidase by cyanide. I - In intact mitochondria |
| Q39998350 | Effect of hydroxycobalamin on the inhibition of cytochrome c oxidase by cyanide. II - In isolated cytochrome C oxidase |
| Q72013088 | Effect of the cyanide antidote hydroxocobalamin on commonly ordered serum chemistry studies |
| Q53319762 | Effect of the use of combination uridine triphosphate, cytidine monophosphate, and hydroxycobalamin on the recovery of neurosensory disturbance after bilateral sagittal split osteotomy: a randomized, double-blind trial. |
| Q72577644 | Effects of Cobalt or Hydroxycobalamin Supplementation on Vitamin B-12 Content and (S)-Methylmalonyl-CoA Mutase Activity of Tissue from Cobalt-Depleted Sheep |
| Q70900514 | Effects of cyanide antidotes used with sodium nitroprusside infusions: sodium thiosulphate and hydroxocobalamin given prophylactically to dogs |
| Q35028766 | Effects of hydroxocobalamin and carboxy-PTIO on nitrergic transmission in porcine anococcygeus and retractor penis muscles |
| Q72658128 | Effects of hydroxocobalamin and haemoglobin on no-mediated relaxations in the rat anococcygeus muscle |
| Q50629690 | Effects of hydroxocobalamin on carboxyhemoglobin measured under physiologic and pathologic conditions. |
| Q73186612 | Effects of hydroxocobalamin on nitrergic transmission in rat anococcygeus and bovine retractor penis muscles: sensitivity to light |
| Q68245005 | Effects of hydroxocobalamin on rat cardiac papillary muscle |
| Q71229452 | Effects of irradiation with gamma rays of cobalt-60 on injectable solutions of cyanocobalamin and hydroxycobalamin |
| Q36363478 | Efficacy of Intravenous Cobinamide Versus Hydroxocobalamin or Saline for Treatment of Severe Hydrogen Sulfide Toxicity in a Swine (Sus scrofa) Model |
| Q90839503 | Efficacy of Intravenous Hydroxocobalamin for Treatment of Sodium Methanethiolate Exposure in a Swine Model (Sus scrofa) of Severe Methanethiol Toxicity |
| Q80311689 | Efficacy of hydroxocobalamin for the treatment of acute cyanide poisoning in adult beagle dogs |
| Q98569753 | Efficacy of intramuscular hydroxocobalamin supplementation in cats with cobalamin deficiency and gastrointestinal disease |
| Q81633278 | Electronic structure and bonding in hydroxocobalamin |
| Q100430846 | Elevated Methemoglobin Levels in a Patient Treated with Hydroxocobalamin After Suspected Cyanide Exposure |
| Q90000071 | Elevated Serum Cobalt Concentrations Associated With Hydroxocobalamin Administration for Refractory Vasoplegia |
| Q80947478 | Elevated plasma cyanide level after hydroxocobalamin infusion for cyanide poisoning |
| Q65002117 | Empiric use of hydroxocobalamin in patients with smoke inhlation injury: Not so fast! |
| Q39483429 | Enhanced biotransformation of carbon tetrachloride by Acetobacterium woodii upon addition of hydroxocobalamin and fructose. |
| Q76496815 | Erythrocyte levels of vitamin B12 after intramuscular administration of cyanocobalamin, hydroxocobalamin and hydroxocobalamin complex |
| Q40115142 | Extreme Hypertriglyceridemia in an Infant with Hemophagocytic Lymphohistiocytosis and Hydroxycobalamin Deficiency |
| Q87380162 | Falsely low carboxyhemoglobin level after hydroxocobalamin therapy |
| Q76587578 | HYDROXOCOBALAMIN AND CYANOCOBALAMIN IN ADDISONIAN ANAEMIA |
| Q76848141 | HYDROXOCOBALAMIN FOR PERNICIOUS ANAEMIA |
| Q38526442 | HYDROXOCOBALAMIN IN LARGE DOSES IN RHEUMATIC HYPERALGIA |
| Q78233231 | HYDROXOCOBALAMIN: EXCRETION AND RETENTION AFTER PARENTERAL DOSES IN ANEMIC AND NONANEMIC SUBJECTS, WITH REFERENCE TO THE TREATMENT OF VITAMIN B12 DEFICIENCY STATES |
| Q76670031 | HYDROXYCOBALAMIN AS A "FLUSHING" DOSE IN THE SCHILLING TEST |
| Q78345246 | HYDROXYCOBALAMIN AS AN ANTIDOTE TO ACRYLONITRILE |
| Q33158589 | Hemodialysis complications of hydroxocobalamin: a case report |
| Q41951683 | Hemodialysis failure secondary to hydroxocobalamin exposure |
| Q70112792 | Hemodynamic effects of hydroxocobalamin in conscious dogs |
| Q94947410 | Hemodynamics after intraosseous administration of hydroxocobalamin or normal saline in a goat model |
| Q48658851 | Hemolysis index to detect degree of hydroxocobalamin interference with common laboratory tests. |
| Q46926000 | Hibiscus sabdariffa increases hydroxocobalamin oral bioavailability and clinical efficacy in vitamin B12 deficiency with neurological symptoms |
| Q44956760 | High doses of hydroxocobalamin in neurologial pains |
| Q89769197 | High-dose hydroxocobalamin achieves biochemical correction and improvement of neuropsychiatric deficits in adults with late onset cobalamin C deficiency |
| Q35096172 | High-dose hydroxocobalamin administered after H2S exposure counteracts sulfide-poisoning-induced cardiac depression in sheep |
| Q33783029 | High-dose hydroxocobalamin for vasoplegic syndrome causing false blood leak alarm |
| Q91909086 | High-dose hydroxocobalamin in end-stage liver disease and liver transplantation |
| Q72151397 | Hydroxocobalamin (vitamin B12a) prevents and reverses endotoxin-induced hypotension and mortality in rodents: role of nitric oxide |
| Q59573134 | Hydroxocobalamin Quantification in Human Plasma by High-Performance Liquid Chromatography Coupled with Electrospray Tandem Mass Spectrometry in a Pharmacokinetic Study |
| Q44734531 | Hydroxocobalamin Therapy of Cyanide Intoxication in Guinea Pigs |
| Q89960062 | Hydroxocobalamin Versus Methylene Blue for Vasoplegic Syndrome in Cardiothoracic Surgery: A Retrospective Cohort |
| Q47266660 | Hydroxocobalamin With or Without Methylene Blue May Improve Fluid Balance in Critically Ill Patients With Vasoplegic Syndrome After Cardiac Surgery: A Report of Two Cases |
| Q91911929 | Hydroxocobalamin administration for treatment of vasoplegic syndrome associated with cardiopulmonary bypass causes red plasma |
| Q73468525 | Hydroxocobalamin analysis and pharmacokinetics |
| Q57695094 | Hydroxocobalamin and Sodium Thiosulfate versus Sodium Nitrite and Sodium Thiosulfate in Acute Cyanide Toxicity |
| Q72766373 | Hydroxocobalamin and cyanocobalamin |
| Q44412518 | Hydroxocobalamin and cyanocobalamin interference on co-oximetry based hemoglobin measurements |
| Q83676706 | Hydroxocobalamin and epinephrine both improve survival in a swine model of cyanide-induced cardiac arrest |
| Q72348698 | Hydroxocobalamin and haemoglobin differentiate between exogenous and neuronal nitric oxide in the rat gastric fundus |
| Q72682660 | Hydroxocobalamin and its long-acting effects in treatment of vitamin B 12 deficiency |
| Q72792274 | Hydroxocobalamin and sodium thiosulfate interfere negatively with measurement of creatine kinase activity |
| Q43234397 | Hydroxocobalamin and sodium thiosulfate versus sodium nitrite and sodium thiosulfate in the treatment of acute cyanide toxicity in a swine (Sus scrofa) model |
| Q47366095 | Hydroxocobalamin as a Rescue Treatment for Refractory Vasoplegic Syndrome After Prolonged Cardiopulmonary Bypass |
| Q36462944 | Hydroxocobalamin as a cyanide antidote |
| Q45996959 | Hydroxocobalamin as a cyanide antidote: safety, efficacy and pharmacokinetics in heavily smoking normal volunteers. |
| Q41879173 | Hydroxocobalamin association during cell culture results in pink therapeutic proteins |
| Q64890052 | Hydroxocobalamin as a Cause of Oxalate Nephropathy. |
| Q36341671 | Hydroxocobalamin dose escalation improves metabolic control in cblC. |
| Q50196453 | Hydroxocobalamin for Vasoplegic Syndrome in Liver Transplantation: Restoration of Blood Pressure Without Vasospasm |
| Q80425538 | Hydroxocobalamin for acute cyanide poisoning in smoke inhalation |
| Q28264759 | Hydroxocobalamin for acute cyanide poisoning: new data from preclinical and clinical studies; new results from the prehospital emergency setting |
| Q83181686 | Hydroxocobalamin for cobalamin C: which dosage? |
| Q69103387 | Hydroxocobalamin for initial and long-term therapy for vitamin B12 deficiency |
| Q81457893 | Hydroxocobalamin for poisoning caused by ingestion of potassium cyanide: a case study |
| Q36837590 | Hydroxocobalamin for severe acute cyanide poisoning by ingestion or inhalation |
| Q91455551 | Hydroxocobalamin for the Treatment of Vasoplegia: A Review of Current Literature and Considerations for Use |
| Q46183590 | Hydroxocobalamin for the treatment of cardiac surgery-associated vasoplegia: a case series |
| Q101136322 | Hydroxocobalamin for the treatment of refractory intraoperative vasoplegia in a patient with history of squamous cell carcinoma and radiation |
| Q46038246 | Hydroxocobalamin hinders hemodialysis. |
| Q39642909 | Hydroxocobalamin in chronic cyanide poisoning |
| Q28279530 | Hydroxocobalamin in cyanide poisoning |
| Q71145524 | Hydroxocobalamin in otoneuropathies |
| Q53742528 | Hydroxocobalamin in the treatment of Leber's hereditary optic atrophy. |
| Q92175423 | Hydroxocobalamin in the treatment of vasodilatory shock |
| Q104102733 | Hydroxocobalamin mimicking intravascular hemolysis in therapeutic plasma exchange |
| Q44037448 | Hydroxocobalamin reduces hyperhomocysteinemia in end-stage renal disease |
| Q50481005 | Hydroxocobalamin supplementation and erythropoisis stimulating agent hyporesponsiveness in haemodialysis patients. |
| Q35029907 | Hydroxocobalamin treatment of acute cyanide poisoning from apricot kernels |
| Q84800712 | Hydroxocobalamin treatment of acute cyanide poisoning from apricot kernels |
| Q42582528 | Hydroxocobalamin treatment of acute cyanide poisoning with a jewellery-cleaning solution |
| Q39855125 | Hydroxocobalamin treatment of hypercyanemia and hypercyanuria following sciatic nerve compression in rabbits |
| Q91310755 | Hydroxocobalamin treatment of refractory vasoplegia in patients with mechanical circulatory support |
| Q44688158 | Hydroxocobalamin uptake into the cerebrospinal fluid after nasal and intravenous delivery in rats and humans |
| Q73307288 | Hydroxocobalamin versus cyanocobalamin |
| Q70074719 | Hydroxocobalamin versus cyanocobalamin in the treatment of tobacco amblyopia |
| Q83565449 | Hydroxocobalamin versus sodium thiosulfate for the treatment of acute cyanide toxicity in a swine (Sus scrofa) model |
| Q80726021 | Hydroxocobalamin versus thiosulfate for cyanide poisoning |
| Q57907208 | Hydroxocobalamin vs cobalt toxicity on rat cardiac and diaphragmatic muscles |
| Q74786259 | Hydroxocobalamin, a nitric oxide scavenger, in the prophylaxis of migraine: an open, pilot study |
| Q79397182 | Hydroxocobalamin. I. Blood levels and urinary excretion of vitamin B12 in man after a single parenteral dose of aqueous hydroxocobalamin, aqueous cyanocobalamin and cyanocobalamin zinc-tannate complex |
| Q72756098 | Hydroxocobalamin. IV. Biological half-life of hydroxocobalamin in the human liver |
| Q71167489 | Hydroxocobalamin. V. Prolonged maintenance of high vitamin B12 blood levels following a short course of hydroxocobalamin injections |
| Q72866955 | Hydroxocobalamin. VI. Comparison of Intestinal Absorption in Man Of Large Doses of Hydroxocobalamin and Cyanocobalamin |
| Q82774138 | Hydroxocobalamin: a better cyanide antidote |
| Q34269208 | Hydroxocobalamin: improved public health readiness for cyanide disasters |
| Q47867966 | Hydroxocobalamin: treatment for smoke inhalation-associated cyanide poisoning. Meeting the needs of fire victims. |
| Q69402859 | Hydroxocobalamine in cyanide poisoning |
| Q64096676 | Hydroxycobalamin Reveals the Involvement of Hydrogen Sulfide in the Hypoxic Responses of Rat Carotid Body Chemoreceptor Cells |
| Q57070043 | Hydroxycobalamin catalyzes the oxidation of diethyldithiocarbamate and increases its cytotoxicity independently of copper ions |
| Q42592175 | Hydroxycobalamin for ethambutol-induced optic neuropathy |
| Q47787349 | Hydroxycobalamin, hyperbaric oxygen and cyanide poisoning. |
| Q48235076 | Hyperbaric oxygen therapy or hydroxycobalamin attenuates surges in brain interstitial lactate and glucose; and hyperbaric oxygen improves respiratory status in cyanide-intoxicated rats. |
| Q67517344 | IGE-mediated reaction to hydroxocobalamin injection in patient with pernicious anaemia |
| Q89994447 | Iatrogenic pediatric hydroxocobalamin overdose |
| Q73810533 | In situ X-ray absorption spectroelectrochemical study of hydroxocobalamin |
| Q100417130 | In vitro comparison of hydroxocobalamin (B12a) and the mitochondrial directed therapy by a succinate prodrug in a cellular model of cyanide poisoning |
| Q48839514 | In vitro demonstration of the antidotal efficacy of hydroxocobalamin in cyanide poisoning. |
| Q46909794 | In vitro effects of hydroxocobalamin after cyanide intoxication |
| Q48177690 | Increase in circulating holotranscobalamin after oral administration of cyanocobalamin or hydroxocobalamin in healthy adults with low and normal cobalamin status. |
| Q74310559 | Inhibitory actions of hydroxocobalamin, cyanocobalamin, and folic acid on the ultraviolet light-induced relaxation of the frog upper oesophageal strip |
| Q71750540 | Interactions between hydroxocobalamin and nitric oxide (NO): evidence for a redox reaction between NO and reduced cobalamin and reversible NO binding to oxidized cobalamin |
| Q43878387 | Interference of hydroxocobalamine treatment on commun biochemical determinations |
| Q81506704 | Interference of the cyanide antidote hydroxocobalamin with carboxyhemoglobin measurements should not limit clinical use in suspected or confirmed cyanide poisoning |
| Q35008986 | Intracellular binding of radioactive hydroxocobalamin to cobalamin-dependent apoenzymes in rat liver |
| Q40216043 | Intraosseous hydroxocobalamin versus intravenous hydroxocobalamin compared to intraosseous whole blood or no treatment for hemorrhagic shock in a swine model |
| Q47739435 | Intraosseous versus intravenous infusion of hydroxocobalamin for the treatment of acute severe cyanide toxicity in a Swine model |
| Q90003275 | Intravenous Hydroxocobalamin Versus Hextend Versus Control for Class III Hemorrhage Resuscitation in a Prehospital Swine Model |
| Q35805162 | Intravenous cobinamide versus hydroxocobalamin for acute treatment of severe cyanide poisoning in a swine (Sus scrofa) model |
| Q86558269 | Intravenous cobinamide versus hydroxocobalamin for acute treatment of severe cyanide poisoning in a swine (Sus scrofa) model |
| Q88636632 | Intravenous hydroxocobalamin and crystal nephropathy |
| Q72075211 | Intravenous treatment with betamethasone phosphate and hydroxycobalamin in some pain syndromes caused by radicular diseases |
| Q80356936 | Is hydroxocobalamin safe and effective for smoke inhalation? Searching for guidance in the haze |
| Q83487073 | Laboratory interferences with the newer cyanide antidote: hydroxocobalamin |
| Q49829889 | Lactate blood measurement in acute cyanide poisoning: effect of preanalytical delay and hydroxocobalamin uses as treatment |
| Q48255460 | Letter in response to "Acquired methemoglobinemia after hydroxocobalamin administration in a patient with burns and inhalation injury". |
| Q42235665 | Letter: Anaphylactic shock due to hydroxocobalamine |
| Q47773506 | Liquid chromatographic mass spectrometric (LC/MS/MS) determination of plasma hydroxocobalamin and cyanocobalamin concentrations after hydroxocobalamin antidote treatment for cyanide poisoning |
| Q87580557 | Long-lasting atypical acneiform eruption with prominent comedones induced by hydroxocobalamin (vitamin B12 ) |
| Q39543565 | Lymphocyte subpopulations in patients with hydroxocobalamin responsive megaloblastic anaemia |
| Q93788892 | Maintenance therapy of pernicious anaemia. Comparison of cyanocobalamin, hydroxocobalamin and a cyanocobalamin-zinc-tannate complex |
| Q79018450 | Mechanism of the long-acting effect of hydroxocobalamine |
| Q69573947 | Metabolic fate of 57Co-labeled hydroxocobalamin and 57Co-labeled 5,6-dimethylbenzimidazolylcobamide coenzyme in rats |
| Q90868926 | Methylene Blue Monotherapy Compared With Combination Therapy With Hydroxocobalamin for the Treatment of Refractory Vasoplegic Syndrome: ARetrospective Cohort Study |
| Q36847813 | Microbial degradation of corrinoids. VI. Reduction of hydroxocobalamin by cell-free particles from Pseudomonas rubescens |
| Q40181879 | Mitochondrial metabolism of hydroxocobalamin: Synthesis of adenosylcobalamin by intact rat liver mitochondria |
| Q92468330 | Modest and variable efficacy of pre-exposure hydroxocobalamin and dicobalt edetate in a porcine model of acute cyanide salt poisoning |
| Q70874304 | Monitoring of cyanocobalamin and hydroxocobalamin during treatment of cyanide intoxication |
| Q38521346 | Motor and psychomotor troubles and metabolic equilibrium in senescence. Treatment by high dose hydroxocobalamine |
| Q95560011 | Multicomponent spectrometric assay of cyanocobalamin and its photoproduct hydroxocobalamin in the presence of ascorbic acid in photolyzed solutions |
| Q82269616 | Multicomponent spectrophotometric assay of cyanocobalamin, hydroxocobalamin and riboflavin |
| Q35803111 | Nasal absorption of hydroxocobalamin in healthy elderly adults |
| Q71152327 | Nature of vitamin B 12 binding. I. Covalent coupling of hydroxocobalamin to soluble and insoluble carriers |
| Q71731367 | Neurological treatment using hydroxocobalamin in high doses. Statistics and comments |
| Q80311694 | Nitric oxide scavenging by hydroxocobalamin may account for its hemodynamic profile |
| Q34434617 | Normalization of plasma vitamin B12 concentration by intranasal hydroxocobalamin in vitamin B12-deficient patients |
| Q71614296 | Occurrence of antibodies against transcobalamin II in relation to the number of and the intervals between depot therapy with hydroxocobalamin |
| Q90938706 | Off to the Races: Comparison of Excited State Dynamics in Vitamin B12 Derivatives Hydroxocobalamin and Aquocobalamin |
| Q72851740 | On the different capacities of hydroxycobalamin and dimethyl-5,6-benzimidazole-cobamide-coenzyme to reduce some adverse effects of adrenal cortex hormones |
| Q37612806 | On the different capacity of hydroxocobalamin and 5,6-dimethyl-benzimidazole-coenzyme to reduct the harmful effects of corticoids |
| Q71961150 | On the properties of hydroxocobalamine base |
| Q72949663 | On the use of the vitamin combination S-benzoyl-thiamine monophosphate, pyridoxine hydrochloride and hydroxocobalamin in some neurological syndromes |
| Q72345711 | On the use of vitamin B 12 in children with brain damage. Comparative studies of the serum level in caynacobalamin and hydroxycobalamin |
| Q46870162 | Optimizing the dose of hydroxocobalamin in cobalamin C (cblC) defect. |
| Q102327182 | Outcomes after the administration of hydroxocobalamin |
| Q93189516 | Parenteral hydroxocobalamin dose intensification in five patients with different types of early onset intracellular cobalamin defects: Clinical and biochemical responses |
| Q72208615 | Patient variation in pernicious anaemia, as shown in a clinical trial of cyanocobalamin, hydroxocobalamin and cyanocobalamin--zinc tannate |
| Q38108105 | Patterns of cyanide antidote use since regulatory approval of hydroxocobalamin in the United States |
| Q96430990 | Pernicious anaemia: self-administration of hydroxocobalamin in the covid-19 crisis |
| Q72016956 | Pharmacokinetics of hydroxocobalamin in dogs |
| Q71238092 | Pharmacokinetics of hydroxocobalamin in smoke inhalation victims |
| Q71145527 | Pharmacological effects of hydroxocobalamin. Antagonism between hydroxocobalamin and cyanates |
| Q53253194 | Photostability of Hydroxocobalamin: Ultrafast Excited State Dynamics and Computational Studies. |
| Q33268564 | Potential interference by hydroxocobalamin on cooximetry hemoglobin measurements during cyanide and smoke inhalation treatments |
| Q36149780 | Preclinical evaluation of injectable reduced hydroxocobalamin as an antidote to acute carbon monoxide poisoning |
| Q47848410 | Prehospital administration of hydroxocobalamin for smoke inhalation-associated cyanide poisoning: 8 years of experience in the Paris Fire Brigade |
| Q41923895 | Prehospital hydroxocobalamin for inhalation injury and cyanide toxicity in the United States - analysis of a database and survey of ems providers |
| Q81538824 | Prevention of hydrogen sulfide (H2S)-induced mouse lethality and cytotoxicity by hydroxocobalamin (vitamin B(12a)) |
| Q67302021 | Prevention of nitroprusside-induced cyanide toxicity with hydroxocobalamin |
| Q55013626 | Prospective long-term evaluation of parenteral hydroxocobalamin supplementation in juvenile beagles with selective intestinal cobalamin malabsorption (Imerslund-Gräsbeck syndrome). |
| Q47840973 | Prospective study of hydroxocobalamin for acute cyanide poisoning in smoke inhalation |
| Q48204767 | Red urinary discolouration following hydroxocobalamin treatment for vasoplegic syndrome |
| Q89945934 | Red urine after hydroxycobalamin administration |
| Q45125482 | Reductive dechlorination of alpha-, beta-, delta-, and gamma-hexachlorocyclohexane isomers by hydroxocobalamin in the presence of either dithiothreitol or titanium(III) citrate as reducing agents |
| Q42935245 | Reductive dechlorination of α-, β-, γ-, and δ-hexachlorocyclohexane isomers with hydroxocobalamin, in soil slurry systems |
| Q42277553 | Relation of blood cyanide to plasma cyanocobalamin concentration after a fixed dose of hydroxocobalamin in cyanide poisoning |
| Q53708914 | Renal excretion of hydroxocobalamin in man. |
| Q80425542 | Reply to: "Is hydroxocobalamin safe and effective for smoke inhalation? Searching for guidance in the haze" |
| Q100661880 | Rescue of Nimodipine-Induced Refractory Vasoplegia With Hydroxocobalamin in Subarachnoid Hemorrhage: A Case Report |
| Q72856746 | Retention and Distribution of B12 Activity, and Requirement for B12, Following Parenteral Administration of Hydroxocobalamin (Vibeden®) |
| Q53719908 | Retention of cyanocobalamin, hydroxocobalamin, and coenzyme B12 after parenteral administration. |
| Q79520337 | Retention of injected hydroxocobalamin versus cyanocobalamin versus liver extract-bound cobalamin |
| Q51546095 | Risk of oxalate nephropathy with the use of cyanide antidote hydroxocobalamin in critically ill burn patients. |
| Q28275698 | Role of hydroxocobalamin in acute cyanide poisoning |
| Q55640466 | Role of vegetarianism, smoking, and hydroxocobalamin in optic neuritis. |
| Q76706694 | STABILITY OF AQUEOUS SOLUTIONS OF HYDROXOCOBALAMIN |
| Q76686843 | STABILITY OF THE COBALAMIN MOIETY IN BUFFERED AQUEOUS SOLUTIONS OF HYDROXOCOBALAMIN |
| Q76866340 | STUDIES ON VITAMIN B12 RETENTION. COMPARISON OF RETENTION FOLLOWING INTRAMUSCULAR INJECTION OF CYANOCOBALAMIN AND HYDROXOCOBALAMIN |
| Q50720526 | Safety of hydroxocobalamin in healthy volunteers in a randomized, placebo-controlled study. |
| Q28365355 | Sensitivity to cyanocobalamin and hydroxocobalamin |
| Q72909033 | Separation of hydroxocobalamin and cyanocobalamin by thin-layer chromatography |
| Q72039528 | Serum binding of hydroxocobalamin |
| Q70641082 | Severe algia of the ORL sphere and hydroxocobalamin in massive doses |
| Q72032304 | Simultaneous determination of hydroxocobalamin and its cyanide complex cyanocobalamin in human plasma by high-performance liquid chromatography. Application to pharmacokinetic studies after high-dose hydroxocobalamin as an antidote for severe cyanid |
| Q34778344 | Single-molecule conformational dynamics of a biologically functional hydroxocobalamin riboswitch |
| Q71001550 | Sodium nitroprusside: comparison of the antidotal effect of hydroxocobalamin and sodium thiosulfate in rabbits |
| Q69896268 | Sodium nitroprusside: pharmacological aspects of its interaction with hydroxocobalamin and thiosulphate |
| Q28273515 | Sodium thiosulfate or hydroxocobalamin for the empiric treatment of cyanide poisoning? |
| Q81536491 | Spectrophotometry of hydroxocobalamin and hemoglobin reveals production of an unanticipated methemoglobin variant |
| Q72731061 | Studies on intestinal absorption of hydroxocobalamin |
| Q72362100 | Study of the mechanisms involved in hydroxocobalamin interference with determination of some biochemical parameters |
| Q57115535 | Successful Renal Transplantation after Presumed Cyanide Toxicity Treated with Hydroxocobalamin and Review of the Literature |
| Q40254423 | Successful Use of Hydroxocobalamin and Sodium Thiosulfate in Acute Cyanide Poisoning: A Case Report with Follow-up |
| Q33144518 | Syncope following intramuscular injection of hydroxocobalamin in a paraplegic patient: indication for oral administration of cyanocobalamin in spinal cord injury patients |
| Q76850042 | THE IONIZATION OF CYANOCOBALAMIN, HYDROXOCOBALAMIN, HYDROXOCOBALAMIN HYDROCHLORIDE, AND HYDROXOCOBALAMIN DIHYDROBROMIDE |
| Q76736223 | THERAPEUTIC APPLICATIONS OF HYDROXOCOBALAMINE, THIAMINE AND PYRIDOXINE IN A CONJOINED FORM |
| Q38526189 | TREATMENT OF RHEUMATIC HYPERALGIAS WITH HYDROXOCOBALAMINE (VIT. B 12 B) 5000 MICROGRAMS) |
| Q70785750 | The antidote effect of thiosulphate and hydroxocobalamin in formation of nitroprusside intoxication of rabbits |
| Q71701191 | The assay of hydroxocobalamin in urine--a possible source of error |
| Q71255544 | The availability of therapeutic hydroxocobalamin to cells |
| Q50103494 | The curious tale of perioperative precision medicine: a story of hydroxocobalamin and cardiac surgery-associated vasoplegia. |
| Q41345896 | The effect of hydroxocobalamin on the nitroprusside-induced relaxation of rat aortic preparations |
| Q72608857 | The nature of the radioactive material in urine after parenteral 57Co hydroxocobalamin |
| Q44511082 | The phagocytic activity of the reticuloendothelial system for colloidal carbon in rats undergoing a treatment with vitamin B complex, with cyanocobalamin, with hydroxycobalamin and with cobamamide |
| Q79420888 | The preparation of radioactive hydroxocobalamin |
| Q44997586 | The use of high-dose hydroxocobalamin for vasoplegic syndrome. |
| Q100301437 | The use of hydroxocobalamin for vasoplegic syndrome in left ventricular assist device patients |
| Q51632404 | The use of hydroxocobalamin in the Schilling test. |
| Q71086717 | The use of hydroxocobalamin in the prophylaxis and treatment of nitroprusside-induced cyanide toxicity |
| Q47148759 | The use of intravenous hydroxocobalamin as a rescue in methylene blue-resistant vasoplegic syndrome in cardiac surgery |
| Q54255536 | Therapeutic concentrations of hydroxocobalamin interferes with several spectrophotometric assays on the Beckman Coulter DxC and AU680 chemistry analyzers. |
| Q72919998 | Thin-layer chromatography of cyanocobalamin, hydroxocobalamin and B12 coenzymes |
| Q46452265 | Thiosulphate and hydroxocobalamin prophylaxis in progressive cyanide poisoning in guinea-pigs |
| Q27629181 | Three-dimensional structure of ATP:corrinoid adenosyltransferase from Salmonella typhimurium in its free state, complexed with MgATP, or complexed with hydroxycobalamin and MgATP |
| Q42289196 | Transcobalamin II mediated delivery of albumin-bound hydroxocobalamin to human liver cells |
| Q47349414 | Treatment of Vasoplegic Syndrome With Intravenous Hydroxocobalamin During Liver Transplantation |
| Q53814668 | Treatment of viral hepatitis with an association of folinic acid and hydroxycobalamin |
| Q76995389 | USE OF HYDROXOCOBALAMIN IN EXPERIMENTAL CYANIDE POISONING |
| Q73151017 | Unavailable hydroxocobalamin in injectable form |
| Q93093107 | Unexpected Complication of Hydroxocobalamin Administration for Refractory Vasoplegia in Orthotopic Liver Transplant: A Case Report |
| Q67835314 | Uptake of hydroxocobalamin by rat liver mitochondria. Binding to a mitochondrial protein |
| Q71324647 | Urinary excretion of hydroxocobalamine and cyanocobalamine after oral administration of large doses |
| Q93092343 | Use of High-Dose Hydroxocobalamin for Septic Shock: A Case Report |
| Q89443740 | Use of Hydroxocobalamin (Vitamin B12a) in Patients With Vasopressor Refractory Hypotension After Cardiopulmonary Bypass: A Case Series |
| Q103023628 | Use of Intravenous Hydroxocobalamin for Vasoplegic Syndrome in Simultaneous Liver-Kidney Transplant: A Case Report |
| Q71112094 | Use of high concentrations of hydroxocobalamin in the treatment of anti-rabies post vaccination reactions |
| Q71145537 | Use of hydroxocobalamin in deficiency (alcoholic) polyneuritis |
| Q71145541 | Use of hydroxocobalamin in rheumatic pains |
| Q38935470 | Utility and outcomes of hydroxocobalamin use in smoke inhalation patients |
| Q71382157 | Value of using 5000 mcg hydroxocobalamin in treatment of visual deficiency in glaucomatous optic atrophy |
| Q41328011 | Vitamin B-12b as an antidote for over-sedation |
| Q54332911 | Wine-Colored Plasma and Urine from Hydroxocobalamin Treatment. |
| Q79646098 | [Action of hydroxocobalamin in the prevention of protein catabolism caused by prednisone. Preliminary note.] |
| Q79480767 | [Action of hydroxycobalamin on the protein metabolism of nerve cells. Histochemical study of te alkaline phosphatases in fatigued animals.] |
| Q72001859 | [Betamethasone associated with hydroxocobalamin in the treatment of neuralgic syndromes] |
| Q78427697 | [CLINICAL APPLICATION OF A NEW VITAMIN B-12 DERIVATIVE (HYDROXOCOBALAMIN) WITH MASSIVE DOSES TO NERVOUS SYSTEM DISEASES.] |
| Q76855849 | [CLINICAL TRIAL OF A NEW VITAMIN B 12 DERIVATIVE, HYDROXOCOBALAMIN, IN NEUROPSYCHIATRIC DISEASES.] |
| Q72399489 | [Clinical observations on the therapeutic activity of dexamethasone associated with hydroxocobalamin] |
| Q54577462 | [Clinical tests of the anti-analgesic action of hydroxocobalamin in lumbar and sciatic pains] |
| Q69926809 | [Comparative study of the effects of hydroxocobalamin and cyanocobalamin on rheumatic pains. (Double blind test)] |
| Q53768085 | [Contribution to the study of hydroxocobalamin in neurology. (Apropos of 18 cases)] |
| Q79505475 | [Contribution to the study of hydroxycobalamin therapy of neurological deficiency syndromes in alcoholics.] |
| Q71930861 | [Determination of the traces of hydroxocobalamin (vitamin B 12a) in the presence of cyanocobalamin (vitamin B 12)] |
| Q71145530 | [Drug therapy of diabetic neuropathies using high doses of hydroxocobalamin] |
| Q72173226 | [Effect of vitamin B12 (hydroxocobalamine) on intraocular pressure] |
| Q69414224 | [Hemodynamic effect of hydroxocobalamin in the chronically implanted conscious dog] |
| Q70402129 | [Hydroxocobalamin and corneal cicatrization. Experimental study and application to tolerance of contact lenses] |
| Q71145534 | [Hydroxocobalamin in clinical pains] |
| Q79460325 | [Hydroxocobalamin in the treatment of hydorcyanic acid poisoning.] |
| Q79491641 | [Hydroxocobalamin, vitamin B12-binding factors and the intrinsic factor.] |
| Q72797521 | [Hydroxocobalamine in long-term treatment of pernicious anemia] |
| Q79426115 | [Hydroxocobalamine: natural depot vitamin B-12] |
| Q74727235 | [Hydroxycobalamin in the treatment of poisoning by both carbon monoxide and cyanide] |
| Q50968436 | [Methylene blue as an inhibitor of the reduction of hydroxocobalamin by carbon monoxide]. |
| Q68942153 | [Neurophysiological findings in cats with large doses of hydroxocobalamine base] |
| Q78404645 | [ON HYDROXOCOBALAMIN THERAPY.] |
| Q79460331 | [On the subject of the therapeutic value of hydroxocobalamin in hydrocyanic acid poisoning.] |
| Q72962491 | [On the treatment of pustulosis palmarum et plantarum. Clinical experience with hydroxocobalamin] |
| Q72414945 | [Possibilities of 5000 gamma hydroxocobalamin in child psychiatry] |
| Q68919328 | [Potassium cyanide poisoning treated with hydroxocobalamin] |
| Q79646093 | [Research on the neurotropic action of hydroxocobalamin and its combination with pyridoxine HCl or with thiamine propvldisulfide. Preliminary note.] |
| Q52268622 | [Results of the oral administration of a compound of amino acids with hydroxocobalamin in a series of aged subjects] |
| Q72791391 | [Retention, distribution and uptake of vitamin B 12 following parenteral administration of hydroxycobalamin (Vibeden)] |
| Q76496810 | [Stability of aqueous solutions of hydroxocobalamin. I. Influence of sterilization heat on the stability of aqueous solutions of hydroxocobalamin and comparison with cyanobalamin solutions and in the presence of other vitamins in the B group and gly |
| Q76496811 | [Stability of aqueous solutions of hydroxocobalamin. II. Stability time of aqueous solutions of hydroxocobalamin at various temperatures and comparison with cyanocobalamin solutions, in the presence of other vitamins in the B group and glycine] |
| Q76496813 | [Stability of aqueous solutions of hydroxocobalamin. III. Stability time of sugar and sorbitol solutions of hydroxocobalamin at various temperatures and comparison with analogous solutions of cyanocobalamin, in the presence of other vitamins of the |
| Q72584793 | [Stabilization of hydroxocobalamin in liver extracts] |
| Q72180105 | [Studies on intestinal absorption of hydroxocobalamin. II. Biological half life of hydroxocobalamin in small intestinal wall] |
| Q68577551 | [Study of the therapeutic action of a combination of vitamins B1, B6 and hydroxocobalamin in large doses] |
| Q72839682 | [The Schilling test performed with Co58-hydroxocobalamin. Considerations on the kinetics of cyano- and hydroxocobalamin] |
| Q79376023 | [The use of hydroxocobalamine (vitamin B-12a) in the treatment of hydrocyanic acid poisoning.] |
| Q68415588 | [Therapeutic trials with hydroxocobalamin at 5000 gamma in pain of the O.R.L. area] |
| Q70067274 | [Treatment of reflex neurodystrophic syndromes of lumbar osteochondrosis using hydroxycobalamin injections] |
| Q68542152 | [Treatment of vertebragenous pain and sensitivity disorders using high doses of hydroxocobalamin] |
| Q83178963 | [Treatment with hydroxocobalamin for cyanide poisoning: a rare cause of pseudohematuria] |
| Q73222095 | [Vitamin B12-variant in cyanide poisoning. Hydroxycobalamin is a new effective antidote] |
| Q29005682 | Cyanokit | has active ingredient | P3781 |
| Q37155 | World Health Organization Model List of Essential Medicines | has part(s) | P527 |
| Category:Hydroxocobalamin | wikimedia | |
| Arabic (ar / Q13955) | هيدروكسوكوبالامين | wikipedia |
| Hidroksokobalamin | wikipedia | |
| cy | Hydrocsocobalamin | wikipedia |
| Hydroxycobalamin | wikipedia | |
| Hydroxocobalamin | wikipedia | |
| Hidroxocobalamina | wikipedia | |
| Basque language (eu / Q8752) | Hidroxokobalamina | wikipedia |
| Persian (fa / Q9168) | هیدروکسوکبالامین | wikipedia |
| Hydroksikobalamiini | wikipedia | |
| Hydroxocobalamine | wikipedia | |
| gl | Hidroxocobalamina | wikipedia |
| הידרוקסיקובלמין | wikipedia | |
| Hidroksokobalamin | wikipedia | |
| ヒドロキソコバラミン | wikipedia | |
| or | ହାଇଡ୍ରୋକ୍ସୋକୋବାଲାମିନ | wikipedia |
| Hidroxocobalamină | wikipedia | |
| Гидроксокобаламин | wikipedia | |
| Serbo-Croatian (sh / Q9301) | Hidroksokobalamin | wikipedia |
| Hidroksokobalamin | wikipedia | |
| Hydroxocobalamin | wikipedia | |
| 羥鈷胺 | wikipedia |
Search more.